Search

Your search of returned 337 results

Virtus Health is pleased to confirm it has amended its bank finance facilities through to 30 June 2021.
Australian-first trial using the power of AI in IVF begins, the world’s biggest prospective clinical trial of AI
Virtus Health is presenting at the UBS Emerging Company Conference today and is pleased to disclose the management presentation
Virtus Health advises that a total of 68,305 fully paid ordinary shares currently held under voluntary escrow are due for release on 5 June 2020.
Melbourne IVF receives $168k funding for research
Notification of FY20 Full Year Results - Reporting Date and Investor Conference Call
Virtus Health Full Year Financial Results FY20 media release
Appendix 4E Preliminary Final Report - 30 June 2020
Financial Results Presentation Full Year 2020